Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)

被引：0
|
作者：
Procopio, G. [1 ]
Prisciandaro, M. [1 ]
Iacovelli, R. [2 ]
Mancini, M. [3 ]
Fornarini, G. [4 ]
Facchini, G. [5 ]
Carteni, G. [6 ]
Napolitano, M. [7 ]
Sternberg, C. N. [8 ,9 ]
Caserta, C. [10 ]
Bregni, M. [11 ]
Massari, F. [12 ]
Buti, S. [13 ]
Biasco, E. [14 ]
De Giorgi, U. [15 ]
Zustovich, F. [16 ]
Ratta, R. [1 ]
Ortega, C. [17 ]
Tortora, G. [18 ]
Verzoni, E. [1 ]
机构：
[1] Fdn IRCCS, Ist Nazl Tumori, Med Oncol, Milan, Italy
[2] Univ Integrata Verona, Azienda Osped, Med Oncol, Verona, Italy
[3] Policlin Umberto 1, Med Oncol, Rome, Italy
[4] Univ San Martino, Azienda Osped, IST Ist Nazl Ric Canc, IRCCS,Med Oncol, Genoa, Italy
[5] Fdn Pascale, IRCCS, Ist Nazl Tumori, Urogynecol, Naples, Italy
[6] Azienda Osped Rilievo Nazl Antonio Cardarelli AOR, Med Oncol, Naples, Italy
[7] Modena Univ Hosp, Dept Oncol, Modena, Italy
[8] San Camillo Hosp, Dept Oncol, Rome, Italy
[9] San Forlanini Hosp, Dept Oncol, Rome, Italy
[10] Azienda Osped Sta Maria, Med Oncol, Terni, Italy
[11] Osped Busto Arsizio, Med Oncol, Busto Arsizio, Italy
[12] AOU Policlin St Orsola Malpighi, Med Oncol, Bologna, Italy
[13] Azienda Osped Parma, Med Oncol, Parma, Italy
[14] Univ S Chiara, Azienda Osped, Med Oncol, Pisa, Italy
[15] Ist Tumori Romagna IRST, Med Oncol, Meldola, Meldola, Italy
[16] Belluno Hosp, AULSS Dolomiti 1, Oncol Dept, Oncol Unit, Belluno, Italy
[17] ASLCN2 Alba Bra CN, Med Oncol, Alba, Italy
[18] Univ Verona, Med Oncol, Verona, Italy
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
901P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)
    Michele, P.
    Ratta, R.
    Iacovelli, R.
    Mancini, M.
    Fornarini, G.
    Facchini, G.
    Carteni, G.
    Napolitano, M.
    Del Bene, G.
    Santini, D.
    Soraru, M. Mariella
    Vitale, M. G.
    Ricotta, R.
    Tucci, M.
    Fedeli, S. Luzi
    Boe, M. G.
    Mecozzi, A.
    Ortega, C.
    Stemberg, C. N.
    Procopio, G.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [2] Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP).
    De Giorgi, Ugo
    Scagliarini, Sarah
    Basso, Umberto
    Galli, Luca
    Mosillo, Claudia
    Caserta, Claudia
    Rossetti, Sabrina
    Guida, Annalisa
    Bearz, Alessandra
    Buti, Sebastiano
    Lo Re, Giovanni
    Valcamonico, Francesca
    Hamzaj, Alketa
    Cognetti, Francesco
    Rastelli, Francesca
    Fornarini, Giuseppe
    Porta, Camillo
    Del Bene, Gabriella
    Turci, Daniele
    Procopio, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Cabozantinib in metastatic renal cell carcinoma (mRCC): Data from UK expanded access program (EAP)
    Lista, A. Gomez de Liano
    Venugopal, B.
    Fife, K.
    Symeonides, S.
    Vasudev, N. S.
    Rudman, S. M.
    Vohra, S.
    Khasati, L.
    Pettinger, C.
    Szabados, B.
    Morrison, L.
    Powles, T.
    Boleti, E.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 317 - 317
  • [4] Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program
    Procopio, Giuseppe
    Prisciandaro, Michele
    Iacovelli, Roberto
    Cortesi, Enrico
    Fornarini, Giuseppe
    Facchini, Gaetano
    Carteni, Giacomo
    Sabbatini, Roberto
    Del Bene, Gabriella
    Galli, Luca
    Caserta, Claudia
    Multari, Andrea Giovanni
    Bregni, Marco
    Massari, Francesco
    Buti, Sebastiano
    De Giorgi, Ugo
    Zustovich, Fable
    Milella, Michele
    Calabro, Fabio
    Mancini, Maria Laura
    Tortora, Giampaolo
    Vernieri, Claudio
    Santini, Daniele
    Soraru, Mariella
    Ricotta, Riccardo
    Masini, Cristina
    Tucci, Marcello
    Fedeli, Stefano Luzi
    Ortega, Cinzia
    Mecozzi, Antonella
    Ratta, Raffaele
    Sternberg, Cora N.
    Verzoni, Elena
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E945 - E951
  • [5] Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma Real-world Data From an Italian Managed Access Program
    Prisciandaro, Michele
    Ratta, Raffaele
    Massari, Francesco
    Fornarini, Giuseppe
    Caponnetto, Salvatore
    Iacovelli, Roberto
    De Giorgi, Ugo
    Facchini, Gaetano
    Scagliarini, Sarah
    Sabbatini, Roberto
    Caserta, Claudia
    Peverelli, Giorgia
    Mennitto, Alessia
    Verzoni, Elena
    Procopio, Giuseppe
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (01): : 42 - 45
  • [6] Safety and efficacy of sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of an Italian expanded-access program (EAP) with subpopulation analysis
    Stemberg, Cora N.
    Porta, Camillo
    Bracarda, Sergio
    Carteni, Giacomo
    Lo Re, Giovanni
    Ruggeri, Enzo M.
    Conte, Pierfranco
    Monfardini, Silvio
    Gasparini, Giampietro
    Ciuffreda, Libero
    Marini, Giovanni
    Bonetti, Andrea
    Heouaine, Abdhelhamid
    Bernardini, Ilaria
    Ravaioli, Alberto
    Labianca, Roberto
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04): : 418 - 418
  • [7] Efficacy and safety data in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) included in the nivolumab expanded access program (EAP) in Italy
    Sabbatini, R.
    Galli, L.
    Pignata, S.
    Lo Re, G.
    Valcamonico, F.
    Defferrari, C.
    Spada, M.
    Santini, D.
    Masini, C.
    Ciuffreda, L.
    Ruggeri, E. M.
    Chioni, A.
    Livi, L.
    Fagnani, D.
    Bonetti, A.
    Giustini, L.
    Duranti, S.
    Procopio, G.
    Caserta, C.
    Carteni, G.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program (vol 42, pg 42, 2019)
    Prisciandaro, M.
    Ratta, R.
    Massari, F.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 412 - 412
  • [9] Cabozantinib in metastatic renal cell carcinoma (mRCC): Real world experience from the UK
    de Liano, Alfonso Gomez
    Venugopal, Balaji
    Fife, Kate
    Khasti, Luma
    Symeonides, Stefan N.
    Pettinger, Claire
    Powles, Thomas
    Rudman, Sarah Maria
    Vasudev, Naveen
    Boleti, Ekaterini
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
    Vitale, Maria Giuseppa
    Scagliarini, Sarah
    Galli, Luca
    Pignata, Sandro
    Lo Re, Giovanni
    Berruti, Alfredo
    Defferrari, Carlotta
    Spada, Massimiliano
    Masini, Cristina
    Santini, Daniele
    Ciuffreda, Libero
    Ruggeri, Enzo Maria
    Bengala, Carmelo
    Livi, Lorenzo
    Fagnani, Daniele
    Bonetti, Andrea
    Giustini, Lucio
    Hamzaj, Alketa
    Procopio, Giuseppe
    Caserta, Claudia
    Sabbatini, Roberto
    [J]. PLOS ONE, 2018, 13 (07):
12345